Recent Company News

• 10:56 PM ET Apr 27, 2025
  

  StreetAccount Summary - Trading higher/lower: Japan mid-day

• 02:54 AM ET Apr 25, 2025
  

  Astellas Pharma reports Q4 core profit ¥72.6B vs FactSet ¥50.42B (¥1381.5000, 0)

• 05:22 PM ET Apr 24, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:58 AM ET Apr 24, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 07:30 PM ET Apr 17, 2025
  

  StreetAccount Sector Summary - Healthcare Weekly Recap

• 01:58 PM ET Apr 16, 2025
  

  Lupin Ltd discloses update on mirabegron patent case with Astellas Pharma (INR 1935.80, 0.00)

• 04:00 PM ET Apr 15, 2025
  

  Court rules in favour of Astellas Pharma's sustained release formulation of mirabegron (Myrbetriq)

• 10:27 AM ET Apr 14, 2025
  

  StreetAccount Summary - Private company transactions for the week ended 12-Apr

• 11:42 PM ET Apr 08, 2025
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (275 total)

• 10:36 PM ET Apr 08, 2025
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (29 total)